Medical Countermeasures Unlocking a New Target Against Crimean-Congo Hemorrhagic Fever VirusGlobal Biodefense StaffJuly 3, 2025
Pathogens Enzyme-Based Anthrax Therapy Shows Promise in Preclinical TrialsGlobal Biodefense StaffJune 17, 2025
Medical Countermeasures Novel Oral Chitosan-Based Compound Shows Promise for Radiological Emergency ResponseGlobal Biodefense StaffJune 12, 2025
Soligenix to Present at Chemical and Biological Defense S&T Conference Antimicrobial Resistance May 4, 2015 …
G7 Nations Call for Action on Antibiotic Resistance, Tropical Diseases Antimicrobial Resistance May 4, 2015 …
Seattle BioMed Rebrands as Center for Infectious Disease Research Medical Countermeasures April 28, 2015 …
